# Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

> **NCT00382070** · PHASE3 · UNKNOWN · sponsor: **NSABP Foundation Inc** · enrollment: 3966 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Letrozole
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00382070
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** 2016-08-25
- **Final completion:** 2025-04
- **Target enrollment:** 3966 (ACTUAL)
- **Last updated:** 2024-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382070, "Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00382070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*